It could be possible that bisphosphonate treatment leads to clinical psychological effectssuch as anxiety and depression since bisphosphonates cross the blood-brain barrier and may suppress the activity of acetylcholinesterase enzymes at the frontal cortex level (51). This evidence concerns the gene ACHE and depressive symptom measurement.